Wealth Enhancement Advisory Services, LLC Moderna, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $44.5 Billion
- Q3 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 8,353 shares of MRNA stock, worth $307,808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,353
Previous 11,894
29.77%
Holding current value
$307,808
Previous $1.41 Million
60.48%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MRNA
# of Institutions
954Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.56 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.48 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$942 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$621 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$266 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $14.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...